Fig. 6

Validation of risk score model and construction of nomogram. A–D Survival analysis between the high- and low-risk score groups in the Validation cohorts. A GSE14468; B GSE37642-GPL96; C GSE37642-GPL570; D GSE71014. Log-rank test. E–H Time-dependent ROC curve analysis of the risk score in the Validation cohorts. E GSE14468; F GSE37642-GPL96; G GSE37642-GPL570; H GSE71014. I Nomogram to predict OS in AML patients. J Time-dependent calibration curve to validate the predictive power of the nomogram. K ROC curve analysis of nomogram and other prognostic factors